Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses
Vector-borne flaviviruses are responsible for nearly half a billion human infections worldwide each year, resulting in millions of cases of debilitating and severe diseases and approximately 115,000 deaths. While approved vaccines are available for some of these viruses, the ongoing efficacy, safety...
Guardado en:
Autores principales: | Jessica J. Harrison, Jody Hobson-Peters, Helle Bielefeldt-Ohmann, Roy A. Hall |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/98b077beb5284b42814796a916b8e7fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Developing a Stabilizing Formulation of a Live Chimeric Dengue Virus Vaccine Dry Coated on a High-Density Microarray Patch
por: Jovin J. Y. Choo, et al.
Publicado: (2021) -
An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
por: Tomoyoshi Komiya, et al.
Publicado: (2021) -
A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies
por: Niraj Mishra, et al.
Publicado: (2020) -
Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection <italic toggle="yes">In Vivo</italic>
por: Florian Douam, et al.
Publicado: (2017) -
The Distribution and Composition of Vector Abundance in Hanoi City, Vietnam: Association with Livestock Keeping and Flavivirus Detection
por: Thang Nguyen-Tien, et al.
Publicado: (2021)